These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Myxoid Leiomyosarcoma of the Uterus: A Clinicopathologic Analysis of 30 Cases and Review of the Literature With Reappraisal of Its Distinction From Other Uterine Myxoid Mesenchymal Neoplasms. Parra-Herran C; Schoolmeester JK; Yuan L; Dal Cin P; Fletcher CD; Quade BJ; Nucci MR Am J Surg Pathol; 2016 Mar; 40(3):285-301. PubMed ID: 26866354 [TBL] [Abstract][Full Text] [Related]
6. BCOR Internal Tandem Duplication in High-grade Uterine Sarcomas. Mariño-Enriquez A; Lauria A; Przybyl J; Ng TL; Kowalewska M; Debiec-Rychter M; Ganesan R; Sumathi V; George S; McCluggage WG; Nucci MR; Lee CH; Fletcher JA Am J Surg Pathol; 2018 Mar; 42(3):335-341. PubMed ID: 29200103 [TBL] [Abstract][Full Text] [Related]
7. Fibromyxoid variant of endometrial stromal sarcoma with atypical bizarre nuclei. Kim HS; Yoon G; Jung YY; Lee YY; Song SY Int J Clin Exp Pathol; 2015; 8(3):3316-21. PubMed ID: 26045860 [TBL] [Abstract][Full Text] [Related]
8. Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group. Croce S; Devouassoux-Shisheboran M; Pautier P; Ray-Coquard I; Treilleux I; Neuville A; Arnould L; Just PA; Belda MALF; Averous G; Leroux A; Mery E; Loussouarn D; Weinbreck N; Le Guellec S; Mishellany F; Morice P; Guyon F; Genestie C Gynecol Oncol; 2022 Nov; 167(2):373-389. PubMed ID: 36114030 [TBL] [Abstract][Full Text] [Related]
10. Endometrial stromal tumors: an update on a group of tumors with a protean phenotype. Oliva E; Clement PB; Young RH Adv Anat Pathol; 2000 Sep; 7(5):257-81. PubMed ID: 10976906 [TBL] [Abstract][Full Text] [Related]
11. BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology. Chiang S; Lee CH; Stewart CJR; Oliva E; Hoang LN; Ali RH; Hensley ML; Arias-Stella JA; Frosina D; Jungbluth AA; Benayed R; Ladanyi M; Hameed M; Wang L; Kao YC; Antonescu CR; Soslow RA Mod Pathol; 2017 Sep; 30(9):1251-1261. PubMed ID: 28621321 [TBL] [Abstract][Full Text] [Related]
13. Targeted RNA expression profiling identifies high-grade endometrial stromal sarcoma as a clinically relevant molecular subtype of uterine sarcoma. Momeni-Boroujeni A; Mohammad N; Wolber R; Yip S; Köbel M; Dickson BC; Hensley ML; Leitao MM; Antonescu CR; Benayed R; Ladanyi M; Lee CH; Chiang S Mod Pathol; 2021 May; 34(5):1008-1016. PubMed ID: 33077922 [TBL] [Abstract][Full Text] [Related]
14. Malignant mesenchymal tumors of the uterus - time to advocate a genetic classification. Rommel B; Holzmann C; Bullerdiek J Expert Rev Anticancer Ther; 2016 Nov; 16(11):1155-1166. PubMed ID: 27602604 [TBL] [Abstract][Full Text] [Related]
15. Prognostic parameters for survival of patients with malignant mesenchymal tumors of the uterus. Nola M; Babić D; Ilić J; Marusić M; Uzarević B; Petrovecki M; Sabioncello A; Kovac D; Jukić S Cancer; 1996 Dec; 78(12):2543-50. PubMed ID: 8952563 [TBL] [Abstract][Full Text] [Related]
16. ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity. Lewis N; Soslow RA; Delair DF; Park KJ; Murali R; Hollmann TJ; Davidson B; Micci F; Panagopoulos I; Hoang LN; Arias-Stella JA; Oliva E; Young RH; Hensley ML; Leitao MM; Hameed M; Benayed R; Ladanyi M; Frosina D; Jungbluth AA; Antonescu CR; Chiang S Mod Pathol; 2018 Apr; 31(4):674-684. PubMed ID: 29192652 [TBL] [Abstract][Full Text] [Related]
17. Clinicopathological and genomic characterization of BCORL1-driven high-grade endometrial stromal sarcomas. Lin DI; Huang RSP; Mata DA; Decker B; Danziger N; Lechpammer M; Hiemenz M; Ramkissoon SH; Ross JS; Elvin JA Mod Pathol; 2021 Dec; 34(12):2200-2210. PubMed ID: 34302054 [TBL] [Abstract][Full Text] [Related]
18. High-grade Endometrial Stromal Sarcoma: Morphologic and Clinical Features, the Role of Immunohistochemistry and Fluorescence in Situ Hybridization in Diagnosis. Alkanat NE; Uner A; Usubutun A Int J Surg Pathol; 2023 Aug; 31(5):521-531. PubMed ID: 35506912 [No Abstract] [Full Text] [Related]
19. [Diagnosis of uterine sarcomas and rare uterine mesenchymal tumours with malignant potential. Guidelines of the French Sarcoma Group and Rare Gynaecological Tumours]. Croce S; Devouassoux-Shisheboran M; Pautier P; Ray-Coquard I; Treilleux I; Neuville A; Arnould L; Just PA; Le Frere Belda MA; Averous G; Leroux A; Bataillon G; Mery E; Loussouarn D; Weinbreck N; Le Guellec S; Mishellany F; Morice P; Guyon F; Genestie C Bull Cancer; 2024 Jan; 111(1):97-116. PubMed ID: 37806863 [TBL] [Abstract][Full Text] [Related]
20. Genomic profiling of BCOR-rearranged uterine sarcomas reveals novel gene fusion partners, frequent CDK4 amplification and CDKN2A loss. Lin DI; Hemmerich A; Edgerly C; Duncan D; Severson EA; Huang RSP; Ramkissoon SH; Connor YD; Shea M; Hecht JL; Ali SM; Vergilio JA; Ross JS; Elvin JA Gynecol Oncol; 2020 May; 157(2):357-366. PubMed ID: 32156473 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]